Articles
FEATURED ARTICLES
-
Article
Jul 28, 2022
RNA vaccines are hugely versatile. They can potentially inoculate against any pathogen for which a protein target is known, for example, influenza, chlamydia, HIV-1 (human immunodeficiency virus 1), Ebola and RSV (respiratory syncytial virus). Self-amplifying RNA (saRNA) is a typ... -
Article
Mar 01, 2022
Precision NanoSystems maintains that mRNA and LNP technologies, microfluidics, and distributed manufacturing will revamp vaccine production.
LATEST ARTICLES
-
Article
Jul 28, 2022
RNA vaccines are hugely versatile. They can potentially inoculate against any pathogen for which a protein target is known, for example, influenza, chlamydia, HIV-1 (human immunodeficiency virus 1), Ebola and RSV (respiratory syncytial virus). Self-amplifying RNA (saRNA) is a typ... -
Article
Jun 09, 2022
Scale-up and downstream processing operations can impact the functionality and stability of mRNA-LNPs in vaccine development including COVID-19 vaccines. -
Article
Mar 01, 2022
Precision NanoSystems maintains that mRNA and LNP technologies, microfluidics, and distributed manufacturing will revamp vaccine production. -
Article
Mar 01, 2022
During development of pharmaceutically-applicable mRNA therapeutics, synthesis, optimization, and formulation must be taken into consideration.
Advanced Search
close- Publications
- Application Notes
- Posters
- Workshops
- Videos & Webinars
- Articles
Browse by Category
-
Application
- Diagnostic and Imaging
- Genetic Medicine
- Hematology
- Metabolic Disorders
- Neuroscience
- Oncology
- Skeletal Disorders
- Targeted Drug Delivery
- Vaccines
- Other Applications
- Cell therapy
-
Formulation
- Liposomes
- Nucleic Acid Lipid Nanoparticles
- Polymeric Nanoparticles
- Other Formulations
-
Payload
- DNA
- microRNA
- mRNA
- siRNA
- Small Molecule Drugs
- Other Payloads
Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.